portfolio growth

Snail Games ($SNAL) launches aggressive Steam Spring Sale with 75% discount on ARK: Survival Ascended, backed by GDC announcements including Bellwright's 1M sales milestone and Echoes of Elysium's 50% review rating improvement.

Three key obstacles—excessive debt, overly conservative portfolios, and high investment fees—prevent Americans from maximizing retirement savings, potentially costing millions in foregone wealth over decades.

CRISPR Therapeutics eyes growth from Casgevy commercialization and pipeline expansion. FDA-approved gene therapy generates revenue while multiple clinical programs advance toward 2026 milestones.

AGNC offers 12.5% yield via mortgage REITs with high leverage; Ares Capital provides 9.6% yield with stable dividends and lower risk through business loans.